Fig. 2

Primary outcome measure (performance on task A and task B; mean + SEM) for the errorless (EL) and trial and error (TEL) treatment arms at baseline and weeks 11, 16 and 26
Primary outcome measure (performance on task A and task B; mean + SEM) for the errorless (EL) and trial and error (TEL) treatment arms at baseline and weeks 11, 16 and 26